中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2015年
4期
10-11,12
,共3页
急性脑梗死%血塞通注射液%丹红注射液
急性腦梗死%血塞通註射液%丹紅註射液
급성뇌경사%혈새통주사액%단홍주사액
Acute cerebral infarction%Xuesaitong injection%Danhong injection
目的：比较研究急性脑梗死应用血塞通或者丹红注射液治疗的临床治疗效果。方法178例急性脑梗死患者随机分为对照组和观察组，各89例，两组患者采取相同的常规治疗的同时，对照组患者应用血塞通注射液治疗，观察组应用丹红注射液治疗，对两组患者的临床治疗效果、神经功能缺损评分(NIHSS)以及Barthel指数(BI)、日常生活能力评分(ADL)进行比较。结果对照组患者治疗后总有效率为71.9%、观察组患者治疗后总有效率为88.8%，两组比较差异有统计学意义(P<0.05)；观察组治疗后的NIHSS评分、BI评分和ADL评分均优于对照组，两组比较差异有统计学意义(P<0.05)。结论丹红注射液治疗急性脑梗死能够更有效的提高治疗效果，改善临床症状，降低神经功能的损伤，提高患者的生活能力，效果优于血塞通，是一种安全可靠的治疗急性脑梗死的药物，值得临床推广应用。
目的：比較研究急性腦梗死應用血塞通或者丹紅註射液治療的臨床治療效果。方法178例急性腦梗死患者隨機分為對照組和觀察組，各89例，兩組患者採取相同的常規治療的同時，對照組患者應用血塞通註射液治療，觀察組應用丹紅註射液治療，對兩組患者的臨床治療效果、神經功能缺損評分(NIHSS)以及Barthel指數(BI)、日常生活能力評分(ADL)進行比較。結果對照組患者治療後總有效率為71.9%、觀察組患者治療後總有效率為88.8%，兩組比較差異有統計學意義(P<0.05)；觀察組治療後的NIHSS評分、BI評分和ADL評分均優于對照組，兩組比較差異有統計學意義(P<0.05)。結論丹紅註射液治療急性腦梗死能夠更有效的提高治療效果，改善臨床癥狀，降低神經功能的損傷，提高患者的生活能力，效果優于血塞通，是一種安全可靠的治療急性腦梗死的藥物，值得臨床推廣應用。
목적：비교연구급성뇌경사응용혈새통혹자단홍주사액치료적림상치료효과。방법178례급성뇌경사환자수궤분위대조조화관찰조，각89례，량조환자채취상동적상규치료적동시，대조조환자응용혈새통주사액치료，관찰조응용단홍주사액치료，대량조환자적림상치료효과、신경공능결손평분(NIHSS)이급Barthel지수(BI)、일상생활능력평분(ADL)진행비교。결과대조조환자치료후총유효솔위71.9%、관찰조환자치료후총유효솔위88.8%，량조비교차이유통계학의의(P<0.05)；관찰조치료후적NIHSS평분、BI평분화ADL평분균우우대조조，량조비교차이유통계학의의(P<0.05)。결론단홍주사액치료급성뇌경사능구경유효적제고치료효과，개선림상증상，강저신경공능적손상，제고환자적생활능력，효과우우혈새통，시일충안전가고적치료급성뇌경사적약물，치득림상추엄응용。
Objective To comparatively research the clinical effects of Xuesaitong injection or Danhong injection in the treatment of acute cerebral infarction.Methods A total of 178 acute cerebral infarction patients were randomly divided into control group and observation group, with 89 cases in each group. On the basis of conventional treatment, the control group received Xuesaitong injection for treatment, while the observation group received Danhong injection. Comparisons were made on clinical effects, national institutes of health stroke scale (NIHSS), Barthel index (BI), and activities of daily living (ADL) between the two groups.Results After the treatment, the total effective rate of the control group was 71.9%, and that of the observation group was 88.8%. The difference between the two groups had statistical significance (P<0.05). The scores of NIHSS, BI and ADL were all higher in the observation group than the control group, and the difference was statistically significant (P<0.05). Conclusion In the treatment of acute cerebral infarction, Danhong injection has better effect than Xuesaitong injection in improving curative effect and clinical symptoms, reducing nerve function injury, and increasing patients’ living ability. Danhong injection is a safe and reliable drug for treating acute cerebral infarction, and it is worth clinical promotion and application.
